Brendon Neuen's Publications

About Brendon Neuen's Publications

Program Lead, Renal and Metabolic
  • Nephrologist and Director, Kidney Trials, Royal North Shore Hospital
  • Clinical Associate Professor, University of Sydney
  • Conjoint Associate Professor, UNSW Sydney
  • Ph.D. ,
  • MBBS(Hons),
  • MSc(Oxon),
  • FRACP,
  • FASN

  • Non-diabetic kidney disease in patients with diabetes undergoing native kidney biopsy

    Internal Medicine Journal Date published:

  • A Framework for Risk-Based Implementation of Combination Therapy in CKD

    Clinical Journal of the American Society of Nephrology Date published:

  • Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases

    JAMA Date published:

  • Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease

    JAMA Date published:

  • Finerenone in Persons with Chronic Kidney Disease without Diabetes

    New England Journal of Medicine Date published:

  • Whole-population trends in obesity across dimensions of inequality in England, 2019-25: a retrospective, longitudinal cohort study of 54 million adults

    The Lancet Diabetes & Endocrinology Date published:

  • Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)

    The Lancet Date published:

  • Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial

    European Journal of Heart Failure Date published:

  • Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

    Nature Medicine Date published:

  • Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure

    JACC: Heart Failure Date published:

  • Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from PARADIGM-HF

    European Journal of Heart Failure Date published:

  • Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas

    European Journal of Heart Failure Date published:

  • Is Placebo Still Ethical in Trials of Incretin Therapies?

    Circulation Date published:

  • Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials

    European Heart Journal Date published:

  • Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials

    American Journal of Preventive Cardiology Date published:

  • Kidney Disease and Heart Failure: Recent Advances and Current Challenges

    JACC: Heart Failure Date published: